Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers

NCT02378714 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02378714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02378714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers
Lead sponsor
Northwestern University
Phase
Phase 4
Overall status
Completed
Start date
July 24, 2015
Completion date
March 13, 2020
Enrollment
300 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, nicotine dependence